Filing Details

Accession Number:
0001415889-24-013129
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-14 16:30:39
Reporting Period:
2024-05-10
Accepted Time:
2024-05-14 16:30:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1106578 A Martine Rothblatt C/O United Therapeutics Corporation
1000 Spring Street
Silver Spring MD 20910
Chairperson & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-10 3,600 $129.49 3,730 No 4 M Direct
Common Stock Disposition 2024-05-10 1,749 $264.44 1,981 No 4 S Direct
Common Stock Disposition 2024-05-10 894 $265.40 1,087 No 4 S Direct
Common Stock Disposition 2024-05-10 619 $267.02 468 No 4 S Direct
Common Stock Disposition 2024-05-10 224 $268.10 244 No 4 S Direct
Common Stock Disposition 2024-05-10 114 $269.13 130 No 4 S Direct
Common Stock Acquisiton 2024-05-13 3,600 $129.49 3,730 No 4 M Direct
Common Stock Disposition 2024-05-13 1,672 $264.39 2,058 No 4 S Direct
Common Stock Disposition 2024-05-13 850 $265.40 1,208 No 4 S Direct
Common Stock Disposition 2024-05-13 647 $266.56 561 No 4 S Direct
Common Stock Disposition 2024-05-13 251 $267.84 310 No 4 S Direct
Common Stock Disposition 2024-05-13 180 $268.89 130 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2024-05-10 3,600 $0.00 3,600 $129.49
Common Stock Stock Options Disposition 2024-05-13 3,600 $0.00 3,600 $129.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
259,469 2014-12-31 2024-12-31 No 4 M Direct
255,869 2014-12-31 2024-12-31 No 4 M Direct
Footnotes
  1. This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
  2. This transaction was executed in multiple trades at prices ranging from $264.015 to $264.985. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $265.08 to $266.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $266.59 to $267.555. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $267.865 to $268.31. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $268.94 to $269.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $263.96 to $264.755. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $265.01 to $266.005. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. This transaction was executed in multiple trades at prices ranging from $266.03 to $267.025. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  10. This transaction was executed in multiple trades at prices ranging from $267.54 to $267.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.